Notably, the expression levels of KLRG1, BTK, CCR2, SCML4 were all associated with neoplasm disease stage (American Joint Committee on Cancer Code) (P = 0.001; P = 0.022; P = 0.004; P = 0.014, respectively; Table 4). This evidence concerns the gene BTK and neoplasm.